Bascome Majors Upgraded (TRN) to Buy on, Nov 6th, 2017
Bascome has made no other calls on TRN in the last 4 months.
There are 3 other peers that have a rating on TRN. Out of the 3 peers that are also analyzing TRN, 0 agree with Bascome's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bascome
- Michael Baudendistel of "Stifel" Maintained at Strong Buy with Decreased Target to $41 on, Friday, October 27th, 2017
- Prashant Rao of "Citigroup" Maintained at Strong Buy with Increased Target to $45 on, Monday, October 2nd, 2017
- Matthew Brooklier of "Buckingham Research" Maintained at Strong Buy with Increased Target to $36 on, Monday, October 2nd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Ananda Baruah Maintained (AAPL) at Strong Buy with Increased Target to $50 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Steven Milunovich Maintained (AAPL) at Strong Buy with Increased Target to $48 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
William Power Maintained (AAPL) at Buy with Increased Target to $48 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Michael Walkley Maintained (AAPL) at Strong Buy with Increased Target to $49 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Tim Long Maintained (AAPL) at Buy with Increased Target to $49 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Jim Suva Maintained (AAPL) at Strong Buy with Increased Target to $50 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Katy Huberty Maintained (AAPL) at Buy and Held Target at $50 on, Nov 3rd, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Toni Sacconaghi Maintained (AAPL) at Buy with Increased Target to $49 on, Nov 3rd, 2017
on: Wed, Nov 01st 2017
by: WOPRAI
on: Fri, Oct 27th 2017
by: WOPRAI
Daniel Mckenzie Maintained (AAL) at Strong Buy with Decreased Target to $65 on, Oct 27th, 2017
on: Fri, Oct 27th 2017
by: WOPRAI
Michael Baudendistel Maintained (TRN) at Strong Buy with Decreased Target to $41 on, Oct 27th, 2017
on: Fri, Oct 20th 2017
by: WOPRAI
Allison Landry Maintained (WERN) at Hold with Decreased Target to $34 on, Oct 20th, 2017